Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Isabelle Borget

Showing results (31-40 of 133) with videos related to

Pageof 14
Sort By:
European Journal of Ophthalmology|July 21, 2021
Costs comparison of treating diabetic macular edema with aflibercept, ranibizumab or dexamethasone at 1 year in France (INVICOST study)Pierre Gascon, Isabelle Borget, Alban Comet, et al.
Biodrugs : Clinical Immunotherapeutics, Biopharmaceuticals and Gene Therapy|April 20, 2024
Impact of Early Access Reform on Oncology Innovation in France: Approvals, Patients, and CostsTess Martin, Catherine Rioufol, Bertrand Favier, et al.
International Journal of Technology Assessment in Health Care|May 21, 2015
INTRODUCTION OF INNOVATIVE MEDICAL DEVICES AT FRENCH UNIVERSITY HOSPITALS: AN OVERVIEW OF HOSPITAL-BASED HEALTH TECHNOLOGY ASSESSMENT INITIATIVESNicolas Martelli, Mathilde Billaux, Isabelle Borget, et al.
World Journal of Surgery|November 16, 2013
Prophylactic level II neck dissection guided by frozen section for clinically node-negative papillary thyroid carcinoma: is it useful?Dana M Hartl, Abir Al Ghuzlan, Isabelle Borget, et al.
Plos One|December 15, 2015
A Systematic Review of the Level of Evidence in Economic Evaluations of Medical Devices: The Example of Vertebroplasty and KyphoplastyNicolas Martelli, Capucine Devaux, Hélène van den Brink, et al.
Targeted Oncology|February 3, 2016
French Health Technology Assessment of Antineoplastic Drugs Indicated in the Treatment of Solid Tumours: Perspective for Future TrendsChristos Chouaid, Isabelle Borget, Eric Braun, et al.
European Journal of Pharmaceutics and Biopharmaceutics : Official Journal of Arbeitsgemeinschaft Fur Pharmazeutische Verfahrenstechnik E.V|June 6, 2006
Application of an acceptance sampling plan for post-production quality control of chemotherapeutic batches in an hospital pharmacyIsabelle Borget, Isabelle Laville, Angelo Paci, et al.
Bulletin Du Cancer|November 7, 2014
[Modalities of management of cancer patients with febrile neutropenia in the oncology emergency unit of Gustave-Roussy and their related costs]Isabelle Borget, Sami Antoun, Elisabeth Chachaty, et al.
American Journal of Clinical Pathology|April 23, 2008
Assessment of the cost of fine-needle aspiration cytology as a diagnostic tool in patients with thyroid nodulesIsabelle Borget, Philippe Vielh, Sophie Leboulleux, et al.
BMC Public Health|August 20, 2010
Factors associated with excessively lengthy treatment of tuberculosis in the eastern Paris region of France in 2004Nadia Valin, Gilles Hejblum, Isabelle Borget, et al.
Pageof 14

Showing results (31-40 of 133) with videos related to

Sort By:
Pageof 14
European Journal of Ophthalmology|July 21, 2021
Costs comparison of treating diabetic macular edema with aflibercept, ranibizumab or dexamethasone at 1 year in France (INVICOST study)Pierre Gascon, Isabelle Borget, Alban Comet, et al.
Biodrugs : Clinical Immunotherapeutics, Biopharmaceuticals and Gene Therapy|April 20, 2024
Impact of Early Access Reform on Oncology Innovation in France: Approvals, Patients, and CostsTess Martin, Catherine Rioufol, Bertrand Favier, et al.
International Journal of Technology Assessment in Health Care|May 21, 2015
INTRODUCTION OF INNOVATIVE MEDICAL DEVICES AT FRENCH UNIVERSITY HOSPITALS: AN OVERVIEW OF HOSPITAL-BASED HEALTH TECHNOLOGY ASSESSMENT INITIATIVESNicolas Martelli, Mathilde Billaux, Isabelle Borget, et al.
World Journal of Surgery|November 16, 2013
Prophylactic level II neck dissection guided by frozen section for clinically node-negative papillary thyroid carcinoma: is it useful?Dana M Hartl, Abir Al Ghuzlan, Isabelle Borget, et al.
Plos One|December 15, 2015
A Systematic Review of the Level of Evidence in Economic Evaluations of Medical Devices: The Example of Vertebroplasty and KyphoplastyNicolas Martelli, Capucine Devaux, Hélène van den Brink, et al.
Targeted Oncology|February 3, 2016
French Health Technology Assessment of Antineoplastic Drugs Indicated in the Treatment of Solid Tumours: Perspective for Future TrendsChristos Chouaid, Isabelle Borget, Eric Braun, et al.
European Journal of Pharmaceutics and Biopharmaceutics : Official Journal of Arbeitsgemeinschaft Fur Pharmazeutische Verfahrenstechnik E.V|June 6, 2006
Application of an acceptance sampling plan for post-production quality control of chemotherapeutic batches in an hospital pharmacyIsabelle Borget, Isabelle Laville, Angelo Paci, et al.
Bulletin Du Cancer|November 7, 2014
[Modalities of management of cancer patients with febrile neutropenia in the oncology emergency unit of Gustave-Roussy and their related costs]Isabelle Borget, Sami Antoun, Elisabeth Chachaty, et al.
American Journal of Clinical Pathology|April 23, 2008
Assessment of the cost of fine-needle aspiration cytology as a diagnostic tool in patients with thyroid nodulesIsabelle Borget, Philippe Vielh, Sophie Leboulleux, et al.
BMC Public Health|August 20, 2010
Factors associated with excessively lengthy treatment of tuberculosis in the eastern Paris region of France in 2004Nadia Valin, Gilles Hejblum, Isabelle Borget, et al.
Pageof 14